CapsoVision to Participate in the Benchmark 14th Annual Discovery Investor Conference
CapsoVision (NASDAQ: CV) announced that senior management will participate in the Benchmark 14th Annual Discovery One-on-One Investor Conference on December 4, 2025 in New York City.
Attending executives include Johnny Wang, President and CEO; David Garcia, SVP Finance; and Doug Atkinson, SVP Global Sales. Investors seeking a one-on-one meeting are asked to contact their Benchmark representative or email Investors@CapsoVision.com.
CapsoVision (NASDAQ: CV) ha annunciato che la direzione senior parteciperà alla Benchmark 14th Annual Discovery One-on-One Investor Conference il 4 dicembre 2025 a New York.
I dirigenti presenti includono Johnny Wang, Presidente e CEO; David Garcia, SVP Finance; e Doug Atkinson, SVP Global Sales. Gli investitori interessati a un incontro one-on-one sono invitati a contattare il rappresentante Benchmark o a inviare un'email a Investors@CapsoVision.com.
CapsoVision (NASDAQ: CV) anunció que la alta dirección participará en la Benchmark 14th Annual Discovery One-on-One Investor Conference el 4 de diciembre de 2025 en la ciudad de Nueva York.
Los ejecutivos presentes incluyen Johnny Wang, Presidente y CEO; David Garcia, SVP de Finanzas; y Doug Atkinson, SVP de Ventas Globales. Los inversores que deseen una reunión individual deben ponerse en contacto con su representante de Benchmark o enviar un correo a Investors@CapsoVision.com.
CapsoVision (NASDAQ: CV)는 고위 경영진이 Benchmark 14th Annual Discovery One-on-One Investor Conference에 2025년 12월 4일 뉴욕시에서 참여할 것이라고 발표했습니다.
참석하는 임원은 Johnny Wang 사장 겸 CEO; David Garcia 재무 수석 부사장(SVP); 그리고 Doug Atkinson 글로벌 세일즈 수석 부사장(SVP)입니다. 일대일 미팅을 원하는 투자자께서는 Benchmark 담당자에게 연락하시거나 Investors@CapsoVision.com으로 이메일을 보내주시기 바랍니다.
CapsoVision (NASDAQ: CV) a annoncé que la direction participera à la Benchmark 14th Annual Discovery One-on-One Investor Conference le 4 décembre 2025 à New York.
Les cadres présents comprennent Johnny Wang, Président et PDG; David Garcia, SVP Finance; et Doug Atkinson, SVP Global Sales. Les investisseurs souhaitant une réunion individuelle sont priés de contacter leur représentant Benchmark ou d'envoyer un e-mail à Investors@CapsoVision.com.
CapsoVision (NASDAQ: CV) gab bekannt, dass das Senior Management am Benchmark 14th Annual Discovery One-on-One Investor Conference am 4. Dezember 2025 in New York City teilnehmen wird.
Zu den anwesenden Führungskräften gehören Johnny Wang, Präsident und CEO; David Garcia, SVP Finanzen; und Doug Atkinson, SVP Global Sales. Investoren, die ein persönliches Gespräch wünschen, werden gebeten, ihren Benchmark-Vertreter zu kontaktieren oder eine E-Mail an Investors@CapsoVision.com zu senden.
CapsoVision (NASDAQ: CV) أعلنت أن الإدارة العليا ستشارك في Benchmark 14th Annual Discovery One-on-One Investor Conference في 4 ديسمبر 2025 في مدينة نيويورك.
ويشمل حضور المدراء التنفيذيين Johnny Wang، الرئيس والرئيس التنفيذي؛ David Garcia، نائب الرئيس الأول للمالية؛ وDoug Atkinson، نائب الرئيس الأول للمبيعات العالمية. يُطلب من المستثمرين الراغبين في اجتماع واحد-إلى-واحد التواصل مع ممثل Benchmark أو إرسال بريد إلكتروني إلى Investors@CapsoVision.com.
- None.
- None.
Company to participate in 1:1 Investor Meetings on December 4, 2025
SARATOGA, Calif., Nov. 20, 2025 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, today announced that Johnny Wang, President and Chief Executive Officer, David Garcia, Senior Vice President of Finance, and Doug Atkinson, Senior Vice President of Global Sales, will participate in the Benchmark 14th Annual Discovery One-on-One Investor Conference on Thursday, December 4, 2025 in New York City.
If you are interested in arranging a one-on-one meeting with CapsoVision’s management team at the conference, please contact your Benchmark representative or reach out to the company directly at Investors@CapsoVision.com.
About CapsoVision
CapsoVision is a commercial-stage medical technology company focused on developing advanced imaging and AI-enabled solutions to transform the detection and diagnosis of gastrointestinal diseases. Its flagship product, CapsoCam Plus®, is a wire-free, panoramic capsule endoscope that enables high-resolution visualization of the small bowel and supports cloud-based or direct capsule video retrieval. The Company’s next pipeline product, CapsoCam Colon™ with enhanced AI, is designed to enable non-invasive colon imaging and polyp detection. With a proprietary platform targeted to expand across multiple GI indications, including esophageal and pancreatic disorders, CapsoVision is advancing a new era in capsule-based diagnostics. For more information on CapsoVision, please visit www.capsovision.com.
Investor Relations Contact
Leigh Salvo
New Street Investor Relations
Investors@CapsoVision.com
Media Contact
Leslie Strickler and Paul Spicer
Être Communications
leslies@etrecommunications.com | (804) 240-0807
pauls@etrecommunications.com | (804) 503-9231
FAQ
When will CapsoVision (CV) management meet investors at the Benchmark Discovery conference?
Which CapsoVision executives will attend the Benchmark 14th Annual Discovery conference?
How can investors arrange a one-on-one meeting with CapsoVision (CV) at the December 4, 2025 conference?
What topics will CapsoVision (CV) management likely cover at the investor meetings on December 4, 2025?
Where is the Benchmark 14th Annual Discovery One-on-One Investor Conference being held for CapsoVision (CV)?
Is there contact information for arranging CapsoVision (CV) investor meetings at the December 4, 2025 event?
